Low-Dose rIL-15 Protects from Nephrotoxic Serum Nephritis via CD8(+) T Cells

Rapid progressive glomerulonephritis (GN) often leads to end-stage kidney disease, driving the need for renal replacement therapy and posing a global health burden. Low-dose cytokine-based immunotherapies provide a new strategy to treat GN. IL-15 is a strong candidate for the therapy of immune-media...

Descripción completa

Detalles Bibliográficos
Autores principales: Mooslechner, Agnes A., Schuller, Max, Artinger, Katharina, Kirsch, Alexander H., Schabhüttl, Corinna, Eller, Philipp, Rosenkranz, Alexander R., Eller, Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688325/
https://www.ncbi.nlm.nih.gov/pubmed/36429085
http://dx.doi.org/10.3390/cells11223656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688325/
https://www.ncbi.nlm.nih.gov/pubmed/36429085
http://dx.doi.org/10.3390/cells11223656

Ejemplares similares